Oncology Brothers: Practice-Changing Cancer Discussions

Oncology Brothers
  • 0,0 (0)
  • TIP
Oncology Brothers: Practice-Changing Cancer Discussions

The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and advanced practice providers (APPs) involved in the care of cancer patients. Drs. Rahul and Rohit Gosain, both esteemed oncologists, bring a wealth of experience and expertise from their general community practice to these discussions. Through short and engaging interviews with world-renowned researchers, clinicians, hematologists, and oncologists, they present practice-changing data in a concise, bite-sized format. Get the latest FDA approvals news, oncology conference highlights, and treatment algorithms in 25 minutes or less. Conversations center around common cancers you see in your clinic like breast cancer, prostate cancer, kidney cancer, bladder cancer, lung cancer, and GI cancers. With new indications and approvals, we talk about how to incorporate this data in your day to day clinical practice. Each episode includes visual presentations so you can follow along within the podcast players and on YouTube @oncbrothers. These visual tools and algorithms will provide an outline on what is covered in each episode. Immediately apply the latest insights and advancements in your daily practice, ensuring the delivery of optimal cancer care to patients within your local communities. If you want to navigate the complexities of your hematology & oncology practice and stay current, the Oncology Brothers Podcast offers invaluable insights and practical takeaways to enhance your professional journey and improve patient outcomes. For more information, please visit: www.oncbrothers.com, and connect with us on Twitter/X/Instagram/TikTok: @oncbrothers, or email us at info@oncbrothers.com

  1. INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer

    2 GÜN ÖNCE · VIDEO

    INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer

    Welcome to another episode of the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain dive deep into the recent FDA approval of Inavolisib for metastatic hormone receptor-positive breast cancer, based on the groundbreaking INAVO120 study. Join us as we chat with Dr. Komal Jhaveri, a medical oncologist and senior author of the study from Memorial Sloan Kettering Cancer Center. We explored the study design, key findings, and the implications of this new treatment option for patients with PIK3CA mutations. Key topics discussed include:•⁠  ⁠Overview of the INAVO120 study and its significance•⁠  ⁠The unique patient population targeted in the study•⁠  ⁠Key findings, including the impressive improvement in progression-free survival (PFS)•⁠  ⁠Side effects and management strategies for patients•⁠  ⁠The importance of genetic testing in treatment decisions Whether you're a healthcare professional or someone interested in the latest advancements in oncology, this episode provides valuable insights into the evolving landscape of breast cancer treatment. Don't forget to like, subscribe, and hit the notification bell for more updates from the Oncology Brothers!#OncologyBrothers #BreastCancer #ENAVOLacib #PIK3CA #CancerResearch #MedicalPodcast #Oncology Website: http://www.oncbrothers.com/ X/Twitter: https://twitter.com/oncbrothers Contact us at info@oncbrothers.com

    23 dk.
  2. How to Approach and Treat Pancreatic Cancer

    6 GÜN ÖNCE · VIDEO

    How to Approach and Treat Pancreatic Cancer

    Welcome to the Oncology Brothers podcast! In this episode, hosts Drs. Rohit and Rahul Gosain are joined by Dr. Eileen O'Reilly, a leading medical oncologist and section head of hepatobiliary and pancreatic cancer at Memorial Sloan Kettering Cancer Center. Together, they delve into the complex treatment landscape of pancreatic cancer.   Episode Highlights: ⁠ ⁠The initial workup for newly diagnosed pancreatic cancer patients, including the importance of imaging and genetic testing. ⁠ ⁠Treatment paradigms for early-stage, borderline resectable, and metastatic pancreatic cancer. ⁠ ⁠The role of multi-agent chemotherapy, including modified FOLFIRINOX and gemcitabine-nab-paclitaxel. ⁠ ⁠Insights into managing patients with high bilirubin levels and the considerations for dose adjustments. ⁠ ⁠The emerging role of targeted therapies and the significance of comprehensive genetic testing in treatment decisions.   Join us as we explore the latest standards of care, the importance of a multidisciplinary approach, and the potential of new therapies in improving outcomes for patients with pancreatic cancer.   Don't forget to like, subscribe, and check out our other episodes for more insights on oncology topics, conference highlights, and recent treatment approvals!   Website: http://www.oncbrothers.com/   X/Twitter: https://twitter.com/oncbrothers   Contact us at info@oncbrothers.com

    22 dk.
  3. Understanding the Impact of Nutrition & Exercise on Cancer Outcomes

    18 KAS · VIDEO

    Understanding the Impact of Nutrition & Exercise on Cancer Outcomes

    In this episode of the Oncology Brothers podcast, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Neil Iyengar, a medical oncologist from Memorial Sloan Kettering Cancer Center, to discuss the critical role of nutrition and exercise in cancer care and recurrence prevention.They tackle common questions from cancer survivors about lifestyle modifications that can help reduce the risk of cancer recurrence. With the current hype around various diets, the discussion delves into the evidence surrounding dietary patterns, exercise, and their impact on overall health and cancer outcomes. Key topics included:•⁠  ⁠The mixed evidence regarding diet and exercise in preventing cancer recurrence.•⁠  ⁠The limitations of BMI as a measure of health and its implications in cancer studies.•⁠  ⁠Insights from recent breast cancer trials on diet and survival rates.•⁠  ⁠The importance of social determinants of health in dietary recommendations.•⁠  ⁠Practical dietary guidelines and the significance of high-fiber, fruit-and-vegetable-rich diets. Dr. Iyengar emphasized the need for ongoing research to provide more specific dietary recommendations for different cancer types and highlights resources available for patients and healthcare providers. Join us for an informative discussion that aimed to empower cancer patients and healthcare professionals with knowledge about lifestyle interventions that can enhance quality of life and potentially improve cancer outcomes. Don't forget to like, subscribe, and hit the notification bell for more insightful discussions from the Oncology Brothers!   Website: http://www.oncbrothers.com/ X/Twitter: https://twitter.com/oncbrothers Contact us at info@oncbrothers.com

    18 dk.
  4. How to Diagnose, Treat, and Follow Neuroendocrine Tumors (NETs)

    14 KAS · VIDEO

    How to Diagnose, Treat, and Follow Neuroendocrine Tumors (NETs)

    In this episode of the Oncology Brothers podcast, hosts Drs. Rohit and Rahul Gosain welcome Dr. Pamela Kunz, a world-renowned medical oncologist from the Yale Cancer Center, to discuss the complex landscape of neuroendocrine tumors (NETs). Join us as we explore:•⁠  ⁠The classification of neuroendocrine tumors based on grade, histological features, and the significance of KI-67.•⁠  ⁠The role of imaging modalities, including Gallium PET-CT and its importance in evaluating disease extent.•⁠  ⁠Treatment strategies for localized versus metastatic NETs, including the use of somatostatin analogs and the nuances of observation versus intervention.•⁠  ⁠Insights into the latest treatment options, including lutetium dotatate, Capecitabine-Temozolomide, and the anticipated approval of Cabozantinib.•⁠  ⁠The potential role of NGS testing and the challenges of combining chemotherapy with immunotherapy in high-grade neuroendocrine tumors. Whether you're a healthcare professional or someone interested in the latest advancements in oncology, this episode provides valuable insights into the management of neuroendocrine tumors. Don't forget to like, subscribe, and check out our other episodes for more discussions on current standard of care treatment options, conference highlights, and new drug approvals. We look forward to seeing you at GI ASCO in January 2025! #OncologyBrothers #NeuroendocrineTumors #CancerCare #MedicalOncology #Podcast #NETs Website: http://www.oncbrothers.com/ X/Twitter: https://twitter.com/oncbrothers Contact us at info@oncbrothers.com

    21 dk.
  5. Palliative Care Management in Cancer

    8 KAS · VIDEO

    Palliative Care Management in Cancer

    In this episode of the Oncology Brothers podcast, hosts Drs. Rahul and Rohit Gosain are joined by esteemed palliative care experts Dr. Janet Abrahm from Dana-Farber Cancer Institute and Dr. Ishwaria Subbiah from Sarah Cannon Research Institute. Together, they delve into the critical topic of palliative care, exploring its evolution from a focus on end-of-life care to an integral part of cancer treatment that enhances both longevity and quality of life. Key discussion points include:•⁠  ⁠The definition and importance of palliative care as an "extra layer of support" for patients, families, and oncologists.•⁠  ⁠The stigma surrounding palliative care and the potential benefits of rebranding it as supportive care.•⁠  ⁠The significant impact of palliative care on symptom management and overall patient outcomes.•⁠  ⁠Innovative approaches to integrating palliative care into oncology practices, including the use of technology and multidisciplinary teams.•⁠  ⁠Effective communication strategies for discussing palliative care and advanced care planning with patients and their families. Join us for this enlightening conversation that aims to demystify palliative care and highlight its essential role in cancer care. Don't forget to like, subscribe, and share your thoughts in the comments!#OncologyBrothers #PalliativeCare #CancerCare #SupportiveCare #QualityOfLife #SymptomManagement #AdvancedCarePlanning Website: http://www.oncbrothers.com/ X/Twitter: https://twitter.com/oncbrothers Contact us at info@oncbrothers.com

    26 dk.
  6. How to Approach to Ovarian Cancer from Community Oncology Perspective

    31 EKI · VIDEO

    How to Approach to Ovarian Cancer from Community Oncology Perspective

    In this episode of the Oncology Brothers podcast, hosts Drs. Rahul and Rohit Gosain welcome Dr. Martina Murphy, an Associate Professor of Medicine and Senior Associate Dean of Graduate Medical Education at the University of Florida, to discuss the current landscape of ovarian cancer. Join us as we dive into the critical aspects of diagnosing and managing ovarian cancer, including:•⁠  ⁠The importance of surgical staging and primary debulking surgery•⁠  ⁠The role of genetic testing, including BRCA and NGS, in treatment planning•⁠  ⁠Adjuvant therapy options, focusing on platinum-based chemotherapy and the use of Bevacizumab•⁠  ⁠Insights into PARP inhibitors and their application in BRCA-positive and wild-type patients•⁠  ⁠Navigating treatment options for relapsed and refractory ovarian cancer, including the use of antibody-drug conjugates like Mirvetuximab and Trastuzumab Deruxtecan (TDXd). Dr. Murphy shares her expertise on the latest advancements in ovarian cancer treatment, the significance of genetic testing, and the management of side effects associated with various therapies. Tune in for a comprehensive overview of the standard of care for ovarian cancer and the evolving treatment landscape. Don't forget to check out our other episodes for more discussions on practice-changing data and current treatment options in oncology! Subscribe to the Oncology Brothers podcast for more insights and updates in the field of oncology! Website: http://www.oncbrothers.com/ X/Twitter: https://twitter.com/oncbrothers Contact us at info@oncbrothers.com

    20 dk.
  7. How to Approach to Endometrial Cancer from Community Oncology Perspective

    24 EKI · VIDEO

    How to Approach to Endometrial Cancer from Community Oncology Perspective

    Join us for an insightful episode of the Oncology Brothers podcast as we dive deep into the world of gynecologic oncology, focusing specifically on endometrial cancer. Hosted by Drs. Rohit and Rahul Gosain, this episode features Dr. Shannon Westin, a Professor of Gynecology, Oncology, and Reproductive Medicine at the MD Anderson Cancer Center. In this episode, we explored:•⁠  ⁠The different histologies of endometrial cancer, including endometrioid, serous, clear cell, and undifferentiated types.•⁠  ⁠The evolving landscape of molecular classification and its impact on treatment decisions.•⁠  ⁠The current treatment paradigms for early-stage and advanced endometrial cancer, including the role of surgery, chemotherapy, and immunotherapy.•⁠  ⁠The significance of NGS (Next-Generation Sequencing) testing in identifying actionable mutations, such as MSI-high tumors and HER2-positive cancers.•⁠  ⁠The latest advancements in adjuvant therapies and the potential of combining chemotherapy with immunotherapy. Whether you're a healthcare professional or simply interested in the latest developments in cancer treatment, this episode is packed with valuable insights and expert opinions. Don't forget to like, subscribe, and check out our other discussions focusing on ovarian cancer and more! Website: http://www.oncbrothers.com/ X/Twitter: https://twitter.com/oncbrothers Contact us at info@oncbrothers.com

    25 dk.
  8. DeLLphi-301 - FDA Approval of Tarlatamab in Patients w/ Prev Treated Small Cell Lung Cancer (SCLC)

    22 EKI · VIDEO

    DeLLphi-301 - FDA Approval of Tarlatamab in Patients w/ Prev Treated Small Cell Lung Cancer (SCLC)

    In this episode of the Oncology Brothers podcast, hosts Drs. Rahul and Rohit Gosain dive into the recent FDA approval of tarlatamab, a groundbreaking bispecific antibody for patients with extensive stage small cell lung cancer. Joined by Dr. Misty Shields from Indiana University, they explore the DeLLphi-301 study design, the efficacy of tarlatamab, and the operational challenges associated with its use. Key topics discussed include:•⁠  ⁠The study's primary endpoint of objective response rate and its implications for patient care.•⁠  ⁠The unique mechanism of action of tarlatamab targeting DLL3 and CD3 T cells.•⁠  ⁠The importance of monitoring for side effects such as cytokine release syndrome (CRS) and immune cell-associated neurotoxicity syndrome (ICANS).•⁠  ⁠Strategies for community oncologists to effectively manage patients receiving this new treatment. Dr. Shields also highlights the significance of patient advocacy and the role of organizations like Longevity Small Cell Smashers in supporting those affected by small cell lung cancer. Tune in for an insightful discussion that sheds light on the future of treatment options for small cell lung cancer and the collaborative efforts needed to ensure patient safety and care. Don't forget to like, subscribe, and hit the notification bell for more updates on the latest in oncology!   Website: http://www.oncbrothers.com/ X/Twitter: https://twitter.com/oncbrothers Contact us at info@oncbrothers.com

    18 dk.
Tümünü Görün (100)

Hakkında

The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and advanced practice providers (APPs) involved in the care of cancer patients. Drs. Rahul and Rohit Gosain, both esteemed oncologists, bring a wealth of experience and expertise from their general community practice to these discussions. Through short and engaging interviews with world-renowned researchers, clinicians, hematologists, and oncologists, they present practice-changing data in a concise, bite-sized format. Get the latest FDA approvals news, oncology conference highlights, and treatment algorithms in 25 minutes or less. Conversations center around common cancers you see in your clinic like breast cancer, prostate cancer, kidney cancer, bladder cancer, lung cancer, and GI cancers. With new indications and approvals, we talk about how to incorporate this data in your day to day clinical practice. Each episode includes visual presentations so you can follow along within the podcast players and on YouTube @oncbrothers. These visual tools and algorithms will provide an outline on what is covered in each episode. Immediately apply the latest insights and advancements in your daily practice, ensuring the delivery of optimal cancer care to patients within your local communities. If you want to navigate the complexities of your hematology & oncology practice and stay current, the Oncology Brothers Podcast offers invaluable insights and practical takeaways to enhance your professional journey and improve patient outcomes. For more information, please visit: www.oncbrothers.com, and connect with us on Twitter/X/Instagram/TikTok: @oncbrothers, or email us at info@oncbrothers.com

Bilgi

Beğenebilirsiniz

  • Two Onc Docs
    Tıp
    Tıp

    Her Hafta

  • Plenary Session
    Bilim
    Bilim

    İki Haftada Bir

  • Mayo Clinic Talks
    Eğitim
    Eğitim

    Haftada İki Kez

  • Oncology Today with Dr Neil Love
    Tıp
    Tıp

    Her Hafta

  • Annals On Call Podcast
    Tıp
    Tıp

    Her Ay

  • ASCO Guidelines
    Tıp
    Tıp

    Güncelleme: 6 gün önce

  • The Curbsiders Internal Medicine Podcast
    Tıp
    Tıp

    Her Hafta

Uygunsuz bölümleri dinlemek için giriş yapın.

Bu şov ile haberdar kalın

Şovları takip etmek, bölümleri kaydetmek ve en son güncellemeleri almak için giriş yapın veya kaydolun.
Ülke veya bölge seçin

Afrika, Orta Doğu ve Hindistan

Asya Pasifik

Avrupa

Latin Amerika ve Karayipler

ABD ve Kanada